Personalized therapy guided by longitudinal liquid biopsies for treatment of leptomeningeal disease from lung adenocarcinoma: A case report

Author:

Lai Mingyao1,Mu Tianhao2,Liu Ming3,Hu Qingjun4,Li Juan4,Huang Tanxiao3,Li Yingmei3,Chen Shifu3,Cai Linbo4

Affiliation:

1. Department of Oncology, Guangdong Sanjiu Brain Hospital, Guangzhou, Guangdong 510510, P.R. China

2. HaploX Biotechnology, Shenzhen, Guangdong 518057, P.R. China

3. HaploX Biotechnology, Shenzhen, Guangdong 518057, P.R. China

4. Department of Oncology, Guangdong Sanjiu Brain Hospital, Guangzhou, Guangdong 510510, P.R. China

Publisher

Spandidos Publications

Reference19 articles.

1. Leptomeningeal metastases in non-small-cell lung cancer;Cheng;Lancet Oncol,2018

2. Diagnostic accuracy of cerebrospinal fluid liquid biopsy and MRI for leptomeningeal metastases in solid cancers: A systematic review and meta-analysis;Nakasu;Neurooncol Adv,2023

3. Advances in targeted therapy in non-small cell lung cancer with actionable mutations and leptomeningeal metastasis;Li;J Clin Pharm Ther,2022

4. Leptomeningeal carcinomatosis in non-small cell lung cancer patients: A continuing challenge in the personalized treatment era;Remon;Cancer Treat Rev,2017

5. BRAF inhibitors in non-small cell lung cancer;Sforza;Cancers (Basel),2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3